VOGO-M 0.2MG TAB

Composition

Voglibose 0.2 mg tablet

Uses of VOGO-M 0.2MG TAB

Type 2 diabetes mellitus (post-prandial/high after-meal blood glucose control), used as add-on to diet/exercise alone or with other antidiabetic medicines

• •Lowers after-meal blood sugar
• •Improves post-prandial glycaemic control
• •Can be used as add-on with other antidiabetics
• •Helps support overall HbA1c reduction

How it works

Voglibose is an alpha-glucosidase inhibitor that delays digestion and absorption of carbohydrates in the small intestine. This reduces the rise in blood glucose after meals and improves post-prandial glycaemic control.

Directions for use

Oral tablet. Usually taken immediately before meals (first bite) as prescribed by the doctor. Swallow with water; follow recommended diet and exercise plan. If a dose is missed, take with the next meal—do not double dose.

Side effects

Common side effects of VOGO-M 0.2MG TAB may include:

• •Flatulence
• •abdominal pain
• •diarrhoea
• •bloating
• •nausea

Warnings & precautions

Use only in type 2 diabetes (not for type 1 diabetes or diabetic ketoacidosis). Caution in patients with gastrointestinal disorders (inflammatory bowel disease, intestinal obstruction, malabsorption) as it can worsen GI symptoms. Monitor blood glucose regularly; risk of hypoglycaemia increases when used with insulin or sulfonylureas—treat low sugar with glucose/dextrose (not sucrose). Use with caution in liver impairment; periodic liver function monitoring may be advised.